January 10, 2008Annual Review of Medicine
Reversing Advanced Heart Failure by Targeting Ca²⁺Cycling
Key result
Targeting the cardiomyocyte calcium-handling pathway in experimental models strongly supports it as a potential clinical intervention for advanced heart failure.
Key Points
- This research aims to explore new therapeutic targets in advanced heart failure by focusing on calcium cycling abnormalities.
- Investigated molecular changes in calcium-handling pathways in heart failure.
- Utilized genetically engineered mouse models and myocardial gene transfer for experimental interventions.
- Examined the impact of restoring calcium defects on heart function.
- Restoration of calcium-handling defects significantly improved cardiac function in model systems.
- Identified crucial molecular players in cardiomyocyte calcium cycling that could be targeted for therapy.
Structured PICO
P
Population
Experimental models of heart failure (genetically engineered mouse models or myocardial gene transfer)
I
Intervention
Restoration of defects in the cardiomyocyte calcium-handling pathway
Preclinical evidence supports targeting the cardiomyocyte calcium-handling pathway as a potential therapeutic strategy for advanced heart failure.
Authors
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Caution against clinical use in advanced HF; leaves open need for translational trials to confirm benefit.
Cite This Study
Kaye et al. (2008) conducted a review in Advanced heart failure. Targeting calcium-handling pathway was evaluated. Targeting the cardiomyocyte calcium-handling pathway in experimental models strongly supports it as a potential clinical intervention for advanced heart failure.